ALNY · ISSUER CIK 1178670
ALNYLAM PHARMACEUTICALS, INC.
Between Aug 1, 2026 and Oct 29, 2026, 2 ALNYLAM PHARMACEUTICALS, INC. insiders reported $0.00 of open-market purchases and $399K of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$399KInsider selling
−$399KNet open-market
Oct 6, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 202616:12 | Oct 2, 2026 | ALNY | EVP, CLO and Secretary | S · Sell | $226.88 | −1,758 | 12,807 | -12% | −$399K | ||
| Sep 22, 202616:07 | Sep 19, 2026 | ALNY | Chief Executive Officer, Director | A · Grant | — | +107 | 95,802 | +0% | — |